A Long-Acting LEAP2 Analog Reduces Hepatic Steatosis and Inflammation and Causes Marked Weight Loss in Mice.
Shankar K, Metzger NP, Lawrence C, Gupta D, Osborne-Lawrence S, Varshney S, Singh O, Richard CP, Zaykov AN, Rolfts R, DuBois BN, Perez-Tilve D, Mani BK, Hammer STG, Zigman JM.
Shankar K, et al. Among authors: gupta d.
Mol Metab. 2024 Apr 30:101950. doi: 10.1016/j.molmet.2024.101950. Online ahead of print.
Mol Metab. 2024.
PMID: 38697291
Free article.